论文部分内容阅读
目的观察稳心颗粒在室性早搏中的疗效。方法选择我院2013年2月至2014年11月收治的发生室性早搏的患者62例。其中观察组32例采用稳心颗粒联合普罗帕酮治疗,对照组30例仅采用普罗帕酮治疗,观察两组治疗1个月后的治疗效果、不良记录及治疗前后的室性期前收缩次数。结果治疗1个月后观察组疗效优于对照组(P<0.05),室性期前收缩次数明显低于对照组(P<0.05)。两组不良反应比较差异无统计学意义(P>0.05)结论稳心颗粒可有效降低室性早搏次数,安全性显著提高,值得临床大力应用推广。
Objective To observe the effect of Wenxin granule in ventricular premature beats. Methods Sixty-two patients with ventricular premature beats admitted to our hospital from February 2013 to November 2014 were selected. Among them, 32 patients in the observation group were treated with Wenxin Granules combined with propafenone, and 30 patients in the control group were only treated with propafenone. The therapeutic effect, bad record and premature ventricular contraction before and after treatment were observed in both groups . Results After 1 month of treatment, the curative effect of the observation group was better than that of the control group (P <0.05), and the number of ventricular contraction before operation was significantly lower than that of the control group (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion Wenxin Granule can effectively reduce the number of ventricular premature beats and improve the safety remarkably, which is worth to be popularized clinically.